Walter E. Stamm, MD, 1945-2009.

H. Handsfield,J. Marrazzo

DOI: https://doi.org/10.1097/OLQ.0b013e3181d7853e

2010-04-01

Sexually Transmitted Diseases

Abstract:

What problem does this paper attempt to address?

Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still’s Disease

Sheng Li,Siting Zheng,Shunli Tang,Yunlei Pan,Shan Zhang,Hong Fang,Jianjun Qiao

DOI: https://doi.org/10.1007/s12016-019-08747-8

2019-01-01

Clinical Reviews in Allergy & Immunology

Abstract:Adult-onset Still’s disease (AOSD) is a rare multisystem autoinflammatory disorder of unknown etiology. AOSD is generally characterized by high spiking fever, arthralgia or arthritis, skin rash, leukocytosis, and hyperferritinemia. Traditionally, AOSD has been treated with non-steroidal anti-inflammatory drugs, corticosteroids, and immunosuppressants. An increasing number of studies have shown that proinflammatory cytokines, such as interleukin-1β, -18, -6, and tumor necrosis factor-α, play key roles in AOSD and may serve as therapeutic targets. In the current review, we provided insights into the roles of these cytokines in the pathogenesis of AOSD and also provided a commentary on the clinical studies of biologic therapy against AOSD.
[Effect of anionic detergents sodium dodecyl sulfate and alkylbenzyl sulfonate on adsorption and transport behavior of several enterotropic viruses in the soil under model conditions].

H. Dizer

1990-09-01

Abstract:The adsorption of poliovirus 3, coxsackievirus B1, and coliphage f2 on soil from an irrigation field loaded for years with waste water and sandy soil from an aquifer was investigated under the influence of two anionic detergents, sodium dodecylsulphate (SDS) and alkylbenzolsulphonate (ABS). The investigation was carried out through batch and column experiments under simulated conditions. The concentrations of both detergents found generally in surface water (0.2-10 mg/l) had no effect on the adsorption of tested viruses. The concentration of 100 mg/l was the lowest intensity that led to an impaired adsorption of viruses on the sediments. The desorbing effect of SDS was relatively higher than ABS. Both detergents gave rise to a desorption and migration of viruses. Especially in soil from an irrigation field the effect was stronger at pH 7.2 than at pH 5.1. Despite low concentrations of detergents in surface water, such procedures as bank filtration, waste water irrigation for the enrichment of groundwater, and the use of sewage sludge on agricultural fields or forest grounds can cause an accumulation of detergents or their metabolites which impairs the binding of viruses to sediments. Therefore, the danger occurrence of a groundwater contamination with enteroviruses should be considered in those sectors.
Adult-Onset Still Disease Presenting With Dermatomyositis-Like Persistent Pruritic Lesions

Jianjun Qiao,Yunlei Pan,Sheng Li,Shunli Tang,Siting Zheng,Dingxian Zhu,Chuanyin Sun,Hong Fang

DOI: https://doi.org/10.1097/DAD.0000000000001447

2019-01-01

American Journal of Dermatopathology

Abstract:Adult-onset Still disease (AOSD) is a rare autoinflammatory condition. The presence of an evanescent, salmon-pink, nonpruritic rash is one of the major diagnostic criteria for the disease. The rash occurs with fever and subsides with defervescence. The presence of dyskeratotic keratinocytes in the upper one-third layer of the epidermis is a distinctive histopathological feature of persistent pruritic lesions associated with AOSD. Here, we report 2 cases of AOSD characterized by persistent pruritic lesions resembling those observed in dermatomyositis. Identifying the clinical and histopathological manifestation of the cutaneous lesions is essential for the early diagnosis of AOSD and for differentiating this condition from those presenting with dyskeratotic cells in the epidermis.
Clinical Characteristics and Outcome of Elderly Onset Adult-Onset Still?s Disease: A 10-Year Retrospective Study

Sheng Li,Shuni Ying,Juan Bai,Yuqian Wang,Changyi Yang,Qingmiao Sun,Hong Fang,Jianjun Qiao

DOI: https://doi.org/10.1016/j.jtauto.2023.100196

2023-01-01

Journal of Translational Autoimmunity

Abstract:Objective: Our objective was to retrospectively analyze the clinical characteristics and outcome of adult-onset Still's disease (AOSD) patients with elderly onset.Methods: Retrospective data of patients diagnosed with AOSD in our institute during 2013-2021 were analyzed. The diagnoses were based on the Yamaguchi criteria for AOSD. All long-term follow-up data were collected from medical records and phone calls.Results: In total, 281 AOSD patients were enrolled in this study, with the median follow-up interval of 47 months. Thirty-two (11.4%, >= 65 years) AOSD patients were classified into the elderly onset groups. Compared to the younger onset group, the percentage of patients with skin rash (p = 0.047), sore throat (p = 0.001), myalgia (p = 0.001), splenomegaly (p = 0.039), hepatosplenomegaly (p = 0.002) and the Pouchot's score (p = 0.002) were significantly lower in the elderly onset group. The death rate (p = 0.014) of elderly onset group is higher than younger onset group, and the independent risk factors of mortality in all AOSD patients were age at onset (HR: 1.115, p = 0.044), disseminated intravascular coagulation (HR: 391.576, p = 0.001) and pleuritis (HR: 23.162, p = 0.033). The probability of relapse was significantly increased in the patients with macrophage activation syndrome (MAS) compared with the patients without MAS (p < 0.001), though the different age groups of AOSD patients with MAS showed no difference in the probability of relapse (p = 0.737).Conclusion: Elderly onset AOSD patients were distinguished by several distinct clinical features compared to younger onset AOSD patients. The frequency of relapse and complications were similar to that of AOSD patients with elderly or younger onset. A higher mortality rate was observed in elderly onset AOSD patients, and the mortality of AOSD patients was related to age at onset, DIC and pleuritis.
Case Report: A Rare Case of Elderly-Onset Adult-Onset Still’s Disease in a Patient With Systemic Lupus Erythematosus

Yasuaki Hirooka,Saki Okuda,Masafumi Sugiyama,Toshihiko Shiga,Yuji Nozaki,Koji Kinoshita,Masanori Funauchi,Itaru Matsumura

DOI: https://doi.org/10.3389/fimmu.2022.822169

IF: 7.3

2022-01-18

Frontiers in Immunology

Abstract:The rare systemic inflammatory disorder ‘adult-onset Still’s disease (AOSD)’ is characterized by recurrent fever, evanescent rash, arthralgia, and leukocytosis with neutrophilia. The Yamaguchi criteria are widely used to diagnose AOSD; these criteria can be used for diagnosis after a wide range of infectious, rheumatic, and neoplastic diseases have been excluded. AOSD generally does not overlap with other rheumatic diseases. We present the rare case of an 80-year-old Japanese woman who presented with arthralgia, fever, and skin rash during treatment for systemic lupus erythematosus (SLE), which was finally diagnosed as an overlap of AOSD. Blood tests revealed leukocytosis with neutrophilia, high C-reactive protein (CRP), and liver dysfunction. Her anti-ds-DNA antibody titer and serum complement titer were at the same level as before and remained stable. We suspected AOSD based on the high serum ferritin level but hesitated to diagnose AOSD because of the patient’s SLE history. We measured serum interleukin (IL)-18; it was extremely high at 161,221 pg/mL, which was strongly suggestive of AOSD. We thus diagnosed AOSD complicated during the course of treatment for SLE. The patient’s arthralgia and high CRP level persisted after we increased her oral prednisolone dose and added oral methotrexate, but her symptoms eventually improved with the addition of intravenous tocilizumab. We note that the presence of autoantibodies or other rheumatic diseases cannot be absolutely ruled out in the diagnosis of AOSD. Although high serum IL-18 levels are not specific for AOSD, the measurement of serum IL-18 may aid in the diagnosis of AOSD in similar rare cases.

immunology
Adult-onset Still's disease—pathogenesis, clinical manifestations, and new treatment options

Sabeeda Kadavath,Petros Efthimiou

DOI: https://doi.org/10.3109/07853890.2014.971052

IF: 5.348

2015-01-02

Annals of Medicine

Abstract:Adult-onset Still's disease (AOSD), a systemic inflammatory disorder, is often considered a part of the spectrum of the better-known systemic-onset juvenile idiopathic arthritis, with later age onset. The diagnosis is primarily clinical and necessitates the exclusion of a wide range of mimicking disorders. AOSD is a heterogeneous entity, usually presenting with high fever, arthralgia, skin rash, lymphadenopathy, and hepatosplenomegaly accompanied by systemic manifestations. The diagnosis is clinical and empirical, where patients are required to meet inclusion and exclusion criteria with negative immunoserological results. There are no clear-cut diagnostic radiological or laboratory signs. Complications of AOSD include transient pulmonary hypertension, macrophage activation syndrome, diffuse alveolar hemorrhage, thrombotic thrombocytopenic purpura and amyloidosis. Common laboratory abnormalities include neutrophilic leukocytosis, abnormal liver function tests, and elevated acute-phase reactants (ESR, CRP, ferritin). Treatment consists of anti-inflammatory medications. Non-steroidal anti-inflammatory drugs have limited efficacy, and corticosteroid therapy and disease-modifying anti-rheumatic drugs are usually required. Recent advances have revealed a pivotal role of proinflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin (IL)-1, IL-6, IL-8, and IL-18 in disease pathogenesis, giving rise to the development of novel targeted therapies aiming at optimal disease control. The review aims to summarize recent advances in pathophysiology and potential therapeutic strategies in AOSD.

medicine, general & internal
Case Report: Adult Onset Still Disease in a 26-year-old Male

Tayler Modlin,Bailey Pickering,Kaihlen Smith,Nanci Van Peursem

Abstract:Introduction: Adult onset still's disease (AOSD) is a systemic inflammatory disease of unknown etiology. It is partially a diagnosis of exclusion, which is why making the diagnosis can be difficult. Case report: A previously healthy 26-year-old male presented to the clinic following a five-day course of generalized body pain and daily spiking fevers up to 101˚ F. Of note, he reported similar symptoms along with a pink rash on his lower extremities four months prior. These previous symptoms were less severe and lasted one month before spontaneously resolving. Over the span of the next two weeks, his symptoms worsened and he was hospitalized. Physical exam showed a patient in moderately acute distress due to pain. He had generalized abdominal tenderness with questionable hepatomegaly. He had decreased range of motion and strength due to pain in his bilateral upper and lower extremities. His large joints (bilateral shoulders, hips, and knees) were tender to palpation. He also had a new salmon-colored maculopapular rash on his left thigh. PMH, PSH, and FH was noncontributory. He had no known drug allergies and took no medications. Lab work revealed leukocytosis, elevated ESR, elevated haptoglobin, and elevated CRP. All other lab values were within normal limits. Patient met diagnostic criteria for AOSD and was started on high dose prednisone with good response. He was discharged from the hospital, to follow up with rheumatology and his PCP. At a follow up visit with rheumatology, the patient tapered off of prednisone and started on Canakinumab 4 mg/kg (240 mg) subcutaneous injections every 4 weeks. He continued this treatment for five months and had no recurrent symptoms, and injections were discontinued. Conclusion: In conclusion, AOSD is a rare disease, but should be considered for patients that present with salmon colored maculopapular rash, pharyngitis, arthralgias or arthritis, and fevers.
Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options

Sara Bindoli,Chiara Baggio,Andrea Doria,Paolo Sfriso,Sfriso, Paolo

DOI: https://doi.org/10.1007/s40265-024-01993-x

2024-03-06

Drugs

Abstract:Adult-onset Still's disease (AOSD) is a multisystemic complex disorder clinically characterised by episodes of spiking fever, evanescent rash, polyarthritis or diffuse arthralgias; multiorgan involvement may develop according to the hyper-inflammatory extent. The pathogenesis of AOSD is not completely recognised. The central role of macrophage activation, which results in T helper 1 (Th1) cell cytokine activation, is well established. Pro-inflammatory cytokines such as interleukin (IL)-1, IL-6 and IL-18 play a fundamental role in disease onset and progression. The disease may develop in both children and adults with overlapping clinical features, and although several subsets depending on the clinical manifestations and the cytokines expressed have been identified, the dichotomy between systemic juvenile idiopathic arthritis (sJIA) and AOSD nowadays has been overcome, and the pathology is considered a disease continuum between ages. Various therapeutic approaches have been evaluated thus far, and different compounds are under assessment for AOSD treatment. Historically, glucocorticoids have been employed for treating systemic manifestations of Still's disease, while conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs) demonstrated efficacy in controlling the articular manifestations. Currently, biological (b) DMARDs are widely employed; IL-1 inhibitors such as anakinra and canakinumab have proven to have high efficacy and an excellent safety profile and the anti-IL-6 tocilizumab is approved for sJIA, with several trials and longitudinal studies confirming its efficacy and safety. Moreover, in the light of the 'window of opportunity', new evidence showed that the earlier these treatments are initiated, the sooner clinical inactivity can be achieved. Other treatment options are being considered since several molecules involved in the disease pathophysiology can be targeted through various mechanisms. This review will provide a broad overview of AOSD pathophysiology, insights into specific organ manifestations and the currently available treatments with the identification of potential therapeutic targets involved in AOSD pathogenesis will be outlined.

pharmacology & pharmacy,toxicology
Unveiling the Mystery of Adult-Onset Still's Disease: A Compelling Case Report

Daniele Sola,Carlo Smirne,Francesco Bruggi,Chiara Bottino Sbaratta,Aubin Cardin Tamen Njata,Guido Valente,Maria Cristina Pavanelli,Rosetta Vitetta,Mattia Bellan,Lorenzo De Paoli,Mario Pirisi

DOI: https://doi.org/10.3390/life14020195

2024-01-30

Life

Abstract:Adult-onset Still's disease (AOSD) is a rare systemic inflammatory disorder. Diagnosis can take a long time, especially in the presence of confounding factors, and it is, to some extent, a process of exclusion. AOSD has life-threating complications ranging from asymptomatic to severe, such as macrophage activation syndrome (MAS), which is also referred to as hemophagocytic lymphohistocytosis (HLH). This condition is correlated with cytokine storm production and monocyte/macrophage overactivation and typically occurs with rash, pyrexia, pancytopenia, hepatosplenomegaly and systemic involvement. Exitus occurs in approximately 10% of cases. For the treatment of MAS-HLH, the Histiocyte Society currently suggests high-dose corticosteroids, with the possible addition of cyclosporine A, anti-interleukin (IL)-1, or IL-6 biological drugs; the inclusion of etoposide is recommended for the most severe conditions. In all cases, a multidisciplinary collaboration involving the resources and expertise of several specialists (e.g., rheumatologist, infectiologist, critical care medicine specialist) is advised. Herein, we provide a detailed description of the clinical case of a previously healthy young woman in which MAS developed as a dramatic onset manifestation of AOSD and whose diagnosis posed a real clinical challenge; the condition was finally resolved by applying the HLH-94 protocol (i.e., etoposide in combination with dexamethasone).

biology
A Diagnostic Dilemma: Adult-Onset Still’s Disease With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome?

Om Parkash,Amritpal S. Anand,Maryna Shayuk

DOI: https://doi.org/10.14740/jmc3858

2023-05-01

Journal of Medical Cases

Abstract:Adult-onset Still’s disease (AOSD) is a rare autoinflammatory condition. It is a diagnosis of exclusion by ruling out all related infectious, inflammatory, autoimmune, and malignant diseases. We present a case of a 23-year-old Caucasian male who presented with fever, night sweats, joint pain, weight loss, and diarrhea. The initial presentation delayed the diagnosis. Upon further investigation, we formulated the diagnosis of AOSD. In sporadic cases, AOSD with secondary hemophagocytic lymphohistiocytosis (HLH), also known as macrophage activation syndrome (MAS), is a devastating disorder of uncontrolled immune activation characterized by clinical and laboratory evidence of extreme inflammation. In case of suspected secondary complications, timely involvement of a multidisciplinary team and starting of appropriate medications is necessary.
Adult-Onset Still's Disease (AOSD)—On the Basis of Own Cases

Małgorzata Wisłowska

DOI: https://doi.org/10.3390/biomedicines12092067

IF: 4.757

2024-09-11

Biomedicines

Abstract:Introduction: Adult-onset Still's disease (AOSD) is a rare chronic autoinflammatory condition characterized by a spiking fever, arthritis, a rash, hepatosplenomegaly, lymphadenopathy, leucocytosis, and hyperferritinemia. It is sometimes accompanied by life-threatening complications like macrophage activation syndrome/hemophagocytic lymphohistiocytosis (MAS/HLH). Treatment options for AOSD include glucocorticoids (GCs), immunosuppressive drugs, biological medications, and Janus kinase (JAK) inhibitors. The features that differentiate MAS/HLH from AOSD are: in MAS/HLH, a different type of fever, which is persistent, a sharp decrease in the number of leukocytes and thrombocytes, a further increase in the level of transaminases and ferritin, significant hepatosplenomegaly, lymphadenopathy, symptoms of the central nervous system (CNS), disseminated intravascular coagulation (DIC) and hemophagocytosis in the bone marrow. This study aimed to evaluate the course of AOSD, which results in MAS/HLD. Patients and methods: Nine AOSD patients, four of whom developed MAS/HLH, were treated at the Rheumatology Clinic in the Central Clinical Hospital of the Ministry of Interior Affairs from 1 January 2015 to 15 March 2020 and at the Rheumatology Clinic in the National Institute of Geriatric, Rheumatology and Rehabilitation from 1 September 2021 to 1 March 2024. Medical history, clinical data, demographic data, laboratory data, imaging data, Hscore, and treatment data were collected. Results: All the patients with MAS and an Hscore above 150 recovered. Discussion: MAS/HLH requires rapid diagnosis as well as treatment with methylprednisolone pulses, cyclosporine A, and etoposide. When comparing patients who developed MAS/HLH with those who did not, possible risk factors were identified: the presence of pregnancy (two cases) and an aggressive course of AOSD. The Hscore is a useful tool for identifying patients with MAS/HLH.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Delayed diagnosis of adult onset Still's disease in 2 cases: diagnostic dilemma in positive antinuclear antibody and tuberculosis endemic areas

Perdana Aditya Rahman,Pandu Tridana Sakti

DOI: https://doi.org/10.1080/00325481.2024.2433930

2024-11-29

Postgraduate Medicine

Abstract:Adult-onset Still's disease (AoSD) is a rare systemic autoinflammatory disorder of unknown etiology that affects young adults. Here, we report two cases of delayed AoSD diagnosis, which was initially diagnosed as tuberculous arthritis and systemic lupus erythematosus (SLE) before referral. In the first case, tuberculous arthritis treatment was commenced based on positive interferon-gamma release assay results, whereas in the second case, SLE was diagnosed based on clinical symptoms and positive antinuclear antibody results. There was no clinical improvement after treatment based on the initial diagnosis, patient referral, or diagnostic elaboration. After further evaluation, the clinical and laboratory features were found to be appropriate for the diagnosis of AoSD. Both patients had anemia, fever, arthritis, and high ferritin levels and were treated with high-dose methylprednisolone followed by methotrexate; clinical improvement was observed, and the ferritin levels reduced.

medicine, general & internal
[Update on Adult-Onset Still's Disease: Diagnosis, Therapy and Guideline]

Stefan Vordenbäumen,Eugen Feist

DOI: https://doi.org/10.1055/a-2000-3446

Abstract:Adult-onset Still's disease (ASOD) is an autoinflammatory disease of unknown etiology which is pathogenetically characterized by an involvement of the innate immune response with activation of neutrophils and an increased secretion of IL-1, IL-6, IL-18, type 1 interferons. Still's disease may occur at any age with distinct variability in signs and symptoms. Recently, the German Society of Rheumatology (DGRh) has issued an AOSD guideline which recommends diagnosing AOSD based on a characteristic combination of symptoms including intermittent fever, rash, arthralgia, and arthritis after exclusion of infections, neoplasms and other rheumatological conditions. Classification criteria according to Yamaguchi may support the clinical diagnosis. Therapy is recommended to include glucocorticosteroids and methotrexate or ciclosporin, at higher activity levels IL1-receptor antagonist anakinra, IL-1β antibody canakinumab, or IL6-receptor antibody tocilizumab. At a high disease activity, anakinra or canakinumab may be employed primarily. Local drug licensing policies may have to be considered, as these substances are not universally approved in these scenarios. Important complications to consider consist in perimyocarditis, a multi-faceted pulmonary involvement, and macrophage activation syndrome (MAS). MAS features multi-organ involvement and cytopenias. Besides supportive measures often requiring intensive care, high dose glucocorticosteroids as well as above named biologics, and if necessary, also etoposide based therapeutic regimen are used.
Risk of Macrophage Activation Syndrome in Patients with Adult-Onset Still's Disease with Skin Involvement: A Retrospective Cohort Study

Yuwei Ding,Shunli Tang,Sheng Li,Changyi Yang,Taoming Liu,Shuni Ying,Dingxian Zhu,Chuanyin Sun,Weiqian Chen,Yu Shi,Hong Fang,Jianjun Qiao

DOI: https://doi.org/10.1016/j.jaad.2021.02.005

IF: 15.487

2021-01-01

Journal of the American Academy of Dermatology

Abstract:Background: Small case series and case reports indicated that atypical persistent pruritic eruptions (PPEs), another type of skin lesions seen in adult-onset Still's disease (AOSD), imply a worse prognosis than typical evanescent rashes. Objective: To investigate clinical characteristics and macrophage activation syndrome (MAS) occurrence in AOSD with PPEs. Methods: A retrospective cohort study analyzed 150 patients with AOSD with rashes at the First Affiliated Hospital of Zhejiang University from January 2013 to December 2019. Results: Patients with AOSD with PPEs had higher lactate dehydrogenase (492.00 U/L vs 382.00 U/L; P < .001) and ferritin (6944.10 ng/ml vs 4286.60 ng/ml; P = .033), and lower fibrinogen (5.05 g/L vs 5.77 g/ L; P = .014) than those with evanescent rashes. Patients with AOSD with PPEs had a higher incidence (17.4% vs 3.1%, P = .006) and cumulative event rate for MAS (P = .008) and tended to receive high-dose glucocorticoid (36% vs 20.3%; P = .036). Multivariate analysis indicated that PPEs (hazard ratio [HR], 5.519; 95% confidence interval [CI], 1.138-26.767; P = .034), aspartate aminotransferase of greater than 120 U/L (HR, 8.084; 95% CI, 1.728-37.826; P = .008), and splenomegaly (HR, 21.152; 95% CI, 2.263-197.711; P = .007) were independent risk factors for MAS. Limitations: Single-center, retrospective nature, small sample size. Conclusion: PPEs indicated increased severity and MAS occurrence versus evanescent rashes. PPEs, aspartate aminotransferase of greater than 120 U/L, and splenomegaly were risk factors for MAS in AOSD with skin involvement.
Metabolomics: Budgeting on a diet.

Grant I. Miura

DOI: https://doi.org/10.1038/nchembio.1944

IF: 14.8

2015-10-20

Nature Chemical Biology

Abstract:
Characterization of genetic landscape and novel inflammatory biomarkers in patients with adult‐onset Still's disease

Joanne Topping,Leon Chang,Fatima Nadat,James A Poulter,Alice Ibbotson,Samuel Lara‐Reyna,Christopher M Watson,Clive Carter,Linda P Pournara,Jan Zernicke,Rebecca L. Ross,Catherine Cargo,Paul A. Lyons,Kenneth G.C. Smith,Francesco Del Galdo,Jürgen Rech,Bruno Fautrel,Eugen Feist,Michael F. McDermott,Sinisa Savic,ImmunAID consortium

DOI: https://doi.org/10.1002/art.43054

2024-11-05

Arthritis & Rheumatology

Abstract:Objectives Adult‐onset Still's disease (AOSD) is systemic autoinflammatory disorder of unknown aetiology. Genetic studies have been limited. Here, we conducted detailed genetic and inflammatory biomarker analysis of a large AOSD cohort to investigate the underlying pathology and identify novel targets for potential treatment. Methods We investigated AOSD cases (n=60) for rare germline and somatic variants using whole exome sequencing with virtual gene panels. Transcriptome profiles were investigated by bulk RNA sequencing whole blood. Cytokine profiling was performed on an extended patient cohort (n=106), alongside measurements of NLRP3 inflammasome activation using a custom assay, and Type I Interferon (IFN) score using a novel method. Results We observed higher‐than‐expected frequencies of rare germline variants associated with monogenic autoinflammatory disorders in AOSD cases (AOSD 38.4% vs healthy controls 20.4%), and earlier onset of putative somatic variants associated with clonal haematopoiesis of indeterminate potential. Transcriptome profiling revealed positive correlation between Still's activity score (SAS) and gene expression associated with the innate immune system. ASC/NLRP3 specks levels and Type I IFN scores were significantly elevated in AOSD cases compared to healthy controls (p=0.0001 and 0.0015 respectively), in addition to several cytokines: IL‐6 (p<0.0001), IL‐10 (p<0.0075), IL‐12p70 (p=0.0005), IL‐18 (p<0.0001), IL‐23 (p<0.0001), IFN‐α2 (p=0.0009), and IFNγ (p=0.0002). Conclusions Our study shows considerable genetic complexity within AOSD and demonstrates the potential utility of the ASC/NLRP3 specks assay for disease stratification and targeted treatment. The enriched genetic variants identified may not, by themselves, be sufficient to cause disease but may contribute to a polygenic model for AOSD.

rheumatology
Adult-onset Still's disease masquerading as acute coronary syndrome: a case report and review of the literature

Indigo Milne,Rhea Kanwar,Whitney Martin,Daniel Egert,Allison Leisgang,Shirley A Albano-Aluquin,Maria P Henao,Christine Kreider,Paddy Ssentongo

DOI: https://doi.org/10.1186/s13256-024-04799-3

2024-10-10

Abstract:Introduction: Adult-onset Still's disease is a rare systemic autoinflammatory disease. We present a case of a young man with a constellation of symptoms and myopericarditis as a complication of this disease. Case: A 36-year-old Hispanic man with no significant past medical history developed a quotidian fever pattern following an upper respiratory tract infection. He initially presented with chest pain concerning for myocardial infarction and underwent cardiac catheterization, which revealed non-obstructive coronary artery disease. He was found to have myopericarditis, significant neutrophilic leukocytosis, and hyperferritinemia. He improved on high-dose corticosteroids but developed steroid-induced psychosis, and 4 months from symptom onset, he finally received tocilizumab, which eventually induced remission without adverse reactions. Discussion: Adult-onset Still's disease should be considered in a patient with fevers of undetermined origin. Due to its multisystemic involvement, adult-onset Still's disease is often a diagnosis arrived at after an extensive cardiac, hematologic, malignant, and infectious workup. Imaging, laboratory testing, and bone marrow biopsy were necessary to rule out alternative etiologies of this patient's presentation. Steroids are the mainstay of treatment because they are easily affordable, although the high risk of adverse effects makes them less desirable. Interleukin-1 inhibitors (anakinra or canakinumab) and interleukin-6 inhibitor tocilizumab are the steroid-sparing biologic agents of choice but are cost-prohibitive. Conclusion: Adult-onset Still's disease should be considered in the differential diagnoses of fever of undetermined origin. Early identification and initiation of treatment are critical to faster recovery and prevention of progression to severe complications. Steroids remain the standard first-line therapy and should be followed by disease-modifying steroid sparing drugs. The social determinants of health may preclude their timely initiation and should alert providers of proactive ways to avoid further delays.
Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

Piero Ruscitti,Paola Cipriani,Francesco Masedu,Daniela Iacono,Francesco Ciccia,Vasiliki Liakouli,Giuliana Guggino,Francesco Carubbi,Onorina Berardicurti,Paola Di Benedetto,Marco Valenti,Giovanni Triolo,Gabriele Valentini,Roberto Giacomelli

DOI: https://doi.org/10.1186/s12916-016-0738-8

IF: 9.3

2016-12-01

BMC Medicine

Abstract:BackgroundAdult-onset Still’s disease (AOSD) is rare inflammatory disease of unknown etiology that usually affects young adults. The more common clinical manifestations are spiking fevers, arthritis, evanescent rash, elevated liver enzymes, lymphadenopathy, hepatosplenomegaly, and serositis. The multi-visceral involvement of the disease and the different complications, such as macrophage activation syndrome, may strongly decrease the life expectancy of AOSD patients.MethodsThis study aimed to identify the positive and negative features correlated with the outcome of patients. A retrospective analysis of AOSD patients prospectively admitted to three rheumatologic centers was performed to identify the clinical features present at the time of diagnosis and to predict the possible outcome. Furthermore, we investigated the as yet to be validated prognostic value of the systemic score previously proposed.ResultsOne hundred consecutive AOSD patients were enrolled. The mean systemic score showed that the majority of patients had a multi-organ involvement. Sixteen patients showed different complications, mainly the macrophage activation syndrome. A strong increase of inflammatory markers was observed. All patients received steroids at different dosages, 55 patients in association with immunosuppressive drugs and 32 in association with biologic agents. Sixteen patients died during the follow-up. Regression analysis showed that the higher values of the systemic score and the presence of AOSD-related complications, assessed at the time of diagnosis, were significantly correlated with patient mortality. A prognostic impact of the systemic score of ≥ 7.0 was reported.ConclusionsOur study showed that a higher systemic score and the presence of AOSD-related complications at the time of diagnosis were significantly associated with mortality. Of note, a cut-off at 7.0 of the systemic score showed a strong prognostic impact in identifying patients at risk of AOSD-related death.

medicine, general & internal
Clinical features and therapeutic response of adult onset Still's disease

Xiao-dan KONG,Wen ZHANG,Qua SHI

DOI: https://doi.org/10.3760/cma.j.issn.1007-7480.2009.05.017

2009-01-01

Abstract:Objective To evaluate the clinical manifestations and responses to treatment of adult onset Still's disease (AOSD).Methods One hundred and four AOSD patients were retrospectively analyzed with clinical features and treatment responses.Results The major clinical features were:spiking fever (100%),evanescent maculopapular rash (95%),polyarthralgia (90%),sore throat (78%),lymphadenectasis (66%),hepatosplenomegaly (57%),hydmhymenitis (30%),neutrephilia (98%),liver dysfunction (62%),increased erythrocyte sedimentation rate (96%) and hyperferritinaemia (99%).Reactive lymphnodes hyperplasia was shown in all patients underwent lymphnode biopsy.94% and 66% patients were treated with glucocorticoid and immune suppressants.Those treated with ≥40 mg/d prednisone or its equivalent dosage achieved quicker remission and less relapses.Conclusion Patients who present with spiking fever,polyarthralgia,maculopapular rash,sore throat and predominant neutrophilia should be considered the possibility of AOSD after tumor or infection are excluded.Glucoeorticoid and immune suppressive drugs are effective medications for AOSD.
Renal cell carcinoma presenting with brain metastasis from a 1.6 cm primary tumor.

H. Chalfin,G. Gurda,H. Hammers,G. Netto,T. Bivalacqua

2013-10-01

Abstract:Small renal cell carcinoma (RCC) tumors are believed to have a negligible risk of metastasis. We report on a 77-year-old man presenting with extremity weakness who was found to have a 2.5 cm brain metastasis from a subsequently discovered 1.6 cm clear cell RCC primary tumor. We review what is known about synchronous and metachronous metastasis from small renal tumors and prognostic features informing treatment for such lesions.

Walter E. Stamm, MD, 1945-2009.

Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still’s Disease

[Effect of anionic detergents sodium dodecyl sulfate and alkylbenzyl sulfonate on adsorption and transport behavior of several enterotropic viruses in the soil under model conditions].

Adult-Onset Still Disease Presenting With Dermatomyositis-Like Persistent Pruritic Lesions

Clinical Characteristics and Outcome of Elderly Onset Adult-Onset Still?s Disease: A 10-Year Retrospective Study

Case Report: A Rare Case of Elderly-Onset Adult-Onset Still’s Disease in a Patient With Systemic Lupus Erythematosus

Adult-onset Still's disease—pathogenesis, clinical manifestations, and new treatment options

Case Report: Adult Onset Still Disease in a 26-year-old Male

Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options

Unveiling the Mystery of Adult-Onset Still's Disease: A Compelling Case Report

A Diagnostic Dilemma: Adult-Onset Still’s Disease With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome?

Adult-Onset Still's Disease (AOSD)—On the Basis of Own Cases

Delayed diagnosis of adult onset Still's disease in 2 cases: diagnostic dilemma in positive antinuclear antibody and tuberculosis endemic areas

[Update on Adult-Onset Still's Disease: Diagnosis, Therapy and Guideline]

Risk of Macrophage Activation Syndrome in Patients with Adult-Onset Still's Disease with Skin Involvement: A Retrospective Cohort Study

Metabolomics: Budgeting on a diet.

Characterization of genetic landscape and novel inflammatory biomarkers in patients with adult‐onset Still's disease

Adult-onset Still's disease masquerading as acute coronary syndrome: a case report and review of the literature

Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

Clinical features and therapeutic response of adult onset Still's disease

Renal cell carcinoma presenting with brain metastasis from a 1.6 cm primary tumor.